ATE318593T1 - Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut - Google Patents

Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Info

Publication number
ATE318593T1
ATE318593T1 AT98921064T AT98921064T ATE318593T1 AT E318593 T1 ATE318593 T1 AT E318593T1 AT 98921064 T AT98921064 T AT 98921064T AT 98921064 T AT98921064 T AT 98921064T AT E318593 T1 ATE318593 T1 AT E318593T1
Authority
AT
Austria
Prior art keywords
tretinoin
skin
vehicle
weight percent
treated
Prior art date
Application number
AT98921064T
Other languages
English (en)
Inventor
Douglas E Kligman
Albert M Kligman
Original Assignee
Douglas E Kligman
Albert M Kligman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Douglas E Kligman, Albert M Kligman filed Critical Douglas E Kligman
Application granted granted Critical
Publication of ATE318593T1 publication Critical patent/ATE318593T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98921064T 1997-05-09 1998-05-11 Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut ATE318593T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4607097P 1997-05-09 1997-05-09
US09/071,017 US6008254A (en) 1997-05-09 1998-05-01 Method of treating skin disorders with high-strength tretinoin

Publications (1)

Publication Number Publication Date
ATE318593T1 true ATE318593T1 (de) 2006-03-15

Family

ID=26723533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921064T ATE318593T1 (de) 1997-05-09 1998-05-11 Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Country Status (8)

Country Link
US (2) US6008254A (de)
EP (1) EP0980243B1 (de)
AT (1) ATE318593T1 (de)
AU (1) AU7374998A (de)
CA (1) CA2288706C (de)
DE (1) DE69833651T2 (de)
ES (1) ES2260834T3 (de)
WO (1) WO1998050023A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AU6589801A (en) * 2000-04-28 2001-11-12 F. Hoffmann-La Roche Ag P-(sulfonyl)aryl and heteroaryls
US6353029B1 (en) 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
JP2004532853A (ja) * 2001-05-09 2004-10-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 酒さを治療する目的での組成物の使用
AU2003209150A1 (en) * 2002-01-04 2003-07-24 Combinatorx, Incorporated Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20040097587A1 (en) * 2002-03-27 2004-05-20 Arbiser Jack L Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
US7390499B2 (en) 2002-04-26 2008-06-24 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
US7704523B2 (en) * 2002-04-26 2010-04-27 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
US20030203013A1 (en) * 2002-04-26 2003-10-30 Xylos Corporation Microbial cellulose wound dressing for treating chronic wounds
US20050019380A1 (en) * 2002-04-26 2005-01-27 Xylos Corporation Microbial cellulose wound dressing for treating chronic wounds
NZ549159A (en) * 2004-02-19 2011-01-28 Chemaphor Inc Topical formulations for the treatment of skin conditions
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
ZA200703385B (en) 2004-09-28 2008-09-25 Chemaphor Inc Compositions and methods for promoting weight gain and feed conversion
US20060251598A1 (en) * 2004-12-02 2006-11-09 Ramirez Jose E System for improved percutaneous absorption of skin benefiting agents
MX2007011486A (es) * 2005-03-24 2007-11-20 Anacor Pharmaceuticals Inc Formulaciones topicas de antibioticos de acido borinico y sus metodos de uso.
JP5612263B2 (ja) * 2005-06-01 2014-10-22 スティーフェル リサーチ オーストラリア ピーティーワイ リミテッド ビタミン製剤
WO2007002531A2 (en) * 2005-06-22 2007-01-04 Thunder Creative Technologies, Inc. Point-of-load power conditioning for memory modules
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
US20070286884A1 (en) * 2006-06-13 2007-12-13 Xylos Corporation Implantable microbial cellulose materials for hard tissue repair and regeneration
US20100298249A1 (en) * 2007-05-11 2010-11-25 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
JP2011500733A (ja) * 2007-10-26 2011-01-06 ケマファー インコーポレーテッド 免疫応答を増強するための組成物および方法
AU2010242502B2 (en) 2009-04-30 2016-11-10 Avivagen Inc. Methods and compositions for improving the health of animals
WO2016022703A1 (en) * 2014-08-06 2016-02-11 Thesan Pharmaceuticals, Inc. Agonists of the ahr receptor pathway having sebosuppressive activity and a method for identifying said agonists
WO2017074982A1 (en) * 2015-10-30 2017-05-04 Patagonia Pharmaceuticals, Llc Isotretinoin formulations and uses and methods thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
MY106263A (en) * 1989-01-19 1995-04-29 Ortho Pharma Corp Method for the treatment or prevention of intrinsically aged skin with retinoids
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
WO1992015290A1 (en) * 1991-02-27 1992-09-17 Kligman Albert M Methods for treatment of scarring fibrotic alopecia
CZ188394A3 (en) * 1992-02-07 1996-02-14 Albert M Kligman Pharmaceutical preparation for the control of inflammatory dermatose cleaning and the use of corticosteroidal matter in combination with a retoidal matter for preparing such preparations
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin

Also Published As

Publication number Publication date
US6228887B1 (en) 2001-05-08
CA2288706C (en) 2007-10-16
WO1998050023A1 (en) 1998-11-12
AU7374998A (en) 1998-11-27
DE69833651T2 (de) 2006-12-28
DE69833651D1 (de) 2006-04-27
ES2260834T3 (es) 2006-11-01
EP0980243A1 (de) 2000-02-23
US6008254A (en) 1999-12-28
EP0980243B1 (de) 2006-03-01
CA2288706A1 (en) 1998-11-12

Similar Documents

Publication Publication Date Title
ATE318593T1 (de) Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut
WANG et al. The effect of glycolic acid on the treatment of acne in Asian skin
Glogau et al. Chemical peels: trichloroacetic acid and phenol
Piérard-Franchimont et al. A randomized, placebo-controlled trial of topical retinol in the treatment of cellulite
Ehrlich et al. Improvement in the appearance of wrinkles with topical transforming growth factor β1 and L-ascorbic acid
AU599135B2 (en) Methods for treatment of sundamaged human skin with retinoids
RU94045258A (ru) Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение
EP0297733A3 (de) Catecholbutane enthaltende Arzneimittel
Paquette et al. Short-contact topical tretinoin therapy to stimulate granulation tissue in chronic wounds
ES2083288T3 (es) Cosmetico que contiene fosfolipidos y carbonos fluorados.
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
GB2210789A (en) Topical application for skin care
EP0801945A3 (de) Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
CA2065412C (en) Methods of preventing and reducing the size of striae distensae lesions
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
DE69717495T2 (de) Verwendung eines terminalia catappa extraktes
KR100339915B1 (ko) 셀레노아미노산의경피적용에의한외인성피부노화의재생법
RU2683248C1 (ru) Композиция лосьона для ухода после бритья за кожей лица, имеющей угревые высыпания
BR0010120A (pt) Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars em umacomposição cosmética ou farmacêutica e processode tratamento cosmético
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
DE4400714A1 (de) Mittel zur Verbesserung der Wirkung extern applizierbarer kosmetischer Präparate
WO2023081685A1 (en) Topical composition and uses thereof
RU2173982C1 (ru) Крем-маска для регенерации поврежденных клеток кожи
Wollina Conservative procedures in skin reconstitution
Panfilov Pre-and Postoperative Skin Care

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties